AmerisourceBergen
AmerisourceBergen (Cencora) is a publicly traded global pharmaceutical distributor serving 1,300+ manufacturers and 180K+ dispensing points through 56 U.S. distribution centers. It generates revenue through wholesale and specialty distribution, manufacturer and provider solutions, animal health, and digital marketplace commerce.
- Company typePublic
- Founded1871
- HeadquartersSeminole, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What AmerisourceBergen does
AmerisourceBergen, now operating as Cencora, is one of the largest global pharmaceutical distribution companies in the United States, founded in 1871 and headquartered in Conshohocken, Pennsylvania. The company is publicly traded on the NYSE under ticker ABC and employs 44,000+ team members. It operates as a critical intermediary between pharmaceutical manufacturers and healthcare providers, with 56 strategically located distribution centers covering 5.6 million square feet across the U.S. and Puerto Rico, and reports local presence in 50+ countries with 1,300+ locations worldwide.
The company's revenue model is anchored in wholesale and specialty pharmaceutical distribution on transaction-based take-rate economics, supplemented by manufacturer solutions (health economics, market access, regulatory consulting, patient access and adherence services, global storage and transport, and channel strategy) and provider solutions (pharmacy, physician practice, hospital, and health system support). Additional revenue streams include animal health distribution (MWI Veterinary Supply, AllyDVM), Cencora Marketplace commerce (25,000+ front-of-store products with 45-day payment terms), and emerging digital therapeutics fulfillment through DTx Connect. Proprietary technology includes a Suspicious Order Monitoring System for controlled substance compliance, blockchain-based DSCSA compliance via the MediLedger project, automated robotics across 30+ distribution centers, and 130,950 square feet of dedicated cold chain storage for biologics, cell and gene therapies, and other temperature-sensitive pharmaceuticals.
AmerisourceBergen serves 1,300+ manufacturers and supplies 180K+ dispensing points, with 92% of U.S. pharmaceutical sales reportedly flowing through distributors. The company is undergoing a brand evolution to Cencora, unifying operating subsidiaries including World Courier, DTx Connect, ABC Order, Marketplace, and Cencora Ventures under a single identity. Recent strategic moves include the Pharma Lex acquisition (January 2023), the Cell and Gene Therapy Integration Hub launch (April 2023), the DTx Connect platform launch (2025), and a Kite Pharma CAR T-cell distribution partnership (June 2026). The company also agreed to a nationwide opioid settlement with court-ordered injunctive relief effective July 1, 2022.
AmerisourceBergen firmographics
Firmographics- Name
- AmerisourceBergen
- Legal name
- AmerisourceBergen Corporation
- Website
- https://amerisourcebergen.com
- Company type
- Public
- Founded year
- 1871
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- AmerisourceBergen (Cencora) is a publicly traded global pharmaceutical distributor serving 1,300+ manufacturers and 180K+ dispensing points through 56 U.S. distribution centers. It generates revenue through wholesale and specialty distribution, manufacturer and provider solutions, animal health, and digital marketplace commerce.
- Ownership category
- akta.pro rank
Where AmerisourceBergen is headquartered
LocationHeadquarters
- HQ city
- Seminole
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
AmerisourceBergen business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Wholesale Pharmaceutical Distribution: Core wholesale distribution services delivering medications from manufacturers to pharmacies, hospitals, and other healthcare providers. Distributors save the healthcare industry $33-53 billion per year in costs.
- Specialty Distribution: Specialty drug distribution for complex therapies including biologics, oncology treatments, and cell and gene therapies requiring specialized handling and cold chain logistics.
- Manufacturer Solutions: Comprehensive services including health economics, market access, regulatory consulting, patient access and adherence support, global storage, transport, outsourced logistics, and channel strategy.
- Pharmacy and Provider Solutions: Solutions powering patient care for pharmacies, physician practices, hospitals and health systems including quality care, operational performance, and access and purchasing services.
- Animal Health Distribution: Distribution, technology and innovation for veterinarians, livestock producers and manufacturers in the animal health sector.
- Marketplace Commerce: Platform fees from the Marketplace connecting sellers with independent retail pharmacies for front-of-store products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Multi-year contract | Custom enterprise pricing for manufacturers and healthcare providers |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels5 records
AmerisourceBergen product offering
Product offeringCore offering
AmerisourceBergen (now Cencora) is a global pharmaceutical distribution company that provides wholesale and specialty distribution services moving medications from 1,300+ manufacturers to 180K+ dispensing points through 56 distribution centers. The company also offers manufacturer solutions (market access, regulatory consulting, patient access services), provider solutions for pharmacies, physician practices, hospitals and health systems, and animal health distribution for veterinarians and livestock producers.
Product overview
AmerisourceBergen (now operating as Cencora) is a pharmaceutical distribution and healthcare solutions company offering a platform-plus-services model. The core offerings include pharmaceutical wholesale and specialty distribution, integrated with proprietary platforms like ABC Order (ordering), Marketplace (front-of-store procurement), and DTx Connect (digital therapeutics fulfillment). The company provides manufacturer solutions (regulatory consulting, patient access, logistics, channel strategy), provider solutions (pharmacy, physician practice, hospital support), and animal health solutions. Specialty services include the Cell and Gene Therapy Integration Hub for advanced therapies and BRx Catalog for targeted manufacturer communications. The company operates 56 distribution centers across the U.S. with over $800M invested in supply chain infrastructure over the past decade.
Differentiator
Problem solved
Functional benefit
Brands
- World Courier: Global courier and logistics services for pharmaceutical and healthcare industries
- DTx Connect
- ABC Order
- Marketplace
- Cencora Impact Foundation
- Cencora Ventures
Products and services
- Pharmaceutical Distribution Wholesale and specialty distribution services that deliver medications from manufacturers to pharmacies, hospitals, health systems and other healthcare providers across the U.S. and 50+ countries.
- Manufacturer Solutions End-to-end services for pharmaceutical manufacturers covering health economics, market access, regulatory consulting, patient access and adherence support, global storage and logistics, and channel strategy across the product lifecycle.
- Provider Solutions Solutions for pharmacies, physician practices, hospitals and health systems covering quality care and patient experience, operational and financial performance, and access and purchasing.
- Animal Health Solutions Distribution, technology and innovation for veterinarians, livestock producers and animal health manufacturers, including consulting, practice optimization, sourcing, distribution, and client engagement technology.
- Cencora Marketplace Digital B2B marketplace integrated with ABC Order that enables independent retail pharmacies to source over 25,000 front-of-store products from verified suppliers with real-time visibility and 45-day payment terms.
- DTx Connect Fully integrated ordering, dispensing, and fulfillment platform that facilitates patient access to physician-ordered digital therapeutics and diagnostics by integrating with electronic medical records.
- Cell and Gene Therapy Integration Hub Integrated hub that improves connectivity throughout the cell and gene therapy treatment journey for patients and providers, supporting specialty logistics and patient support services.
- ABC Order Pharmacy ordering platform enabling pharmacies to order prescription products, integrated with Marketplace for consolidated front-of-store and back-of-store procurement.
- Nucleus Solution (Next-Generation) Practice management solution for specialty physician practices, with a next-generation version piloted in multi-site specialty physician practices in June 2026.
- BRx Catalog Targeted customer communications tool that helps pharmacists raise awareness of manufacturer products and aids in removing cost barriers for patients by delivering product messaging to the right audience.
Quantifiable outcome
- Healthcare industry cost savings of $33-53 billion per year through pharmaceutical distribution
- +1 more outcomes
Companies that use AmerisourceBergen
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles6 records
AmerisourceBergen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
AmerisourceBergen partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, emerging, regional and strategic.
- Kite PharmacorePartnership to support U.S. distribution of Kite's CAR T-cell therapies, announced June 2026, expanding cell therapy distribution capabilities.
- Digital Therapeutics ManufacturersemergingDTx Connect platform enables prescribing and fulfillment of digital therapeutics and diagnostics, integrating with electronic medical records for patient access.
- Cell and Gene Therapy ManufacturerscoreCell and Gene Therapy Integration Hub launched April 2023 to improve connectivity throughout the treatment journey for patients and providers.
- Centers for Disease Control and Prevention (CDC)coreFormal role as network administrator placing orders with CDC on behalf of eligible Good Neighbor Pharmacy and Elevate Provider Network members for Federal Retail Pharmacy Program.
- State of CaliforniaregionalSupport for State of California in distributing Pfizer-BioNTech COVID-19 vaccines to small physician practices.
- Merck and RidgebackcoreDistribution support for Molnupiravir COVID-19 therapy following US FDA Emergency Use Authorization.
- Innomar Strategies (Government of Canada)regionalAgreement with Government of Canada to support COVID-19 vaccine distribution through Innomar Strategies subsidiary.
- Mass General BrighamregionalDeveloped a highly accurate and user-friendly COVID-19 vaccine tracker for Mass General Brigham in just 18 days to meet urgent customer needs during the pandemic.
- U.S. Department of Health and Human Services (HHS)corePartnership for distribution of COVID-19 therapies approved for Emergency Use Authorization. AmerisourceBergen has shipped over 3.6 million patient courses of COVID-19 therapies to sites of care throughout the United States.
- Gilead SciencescoreDistribution partnership for Veklury (Remdesivir) COVID-19 therapy, including supply and distribution updates during the pandemic.
- Eli LillycoreDistribution of bamlanivimab antibody therapy following FDA Emergency Use Authorization.
- RegeneroncoreDistribution partnership for casirivimab and imdevimab antibody cocktail following FDA EUA.
- MediLedger ProjectstrategicBlockchain initiative for pharmaceutical supply chain security as part of the MediLedger project, playing a leading role in pharma's digital transformation for DSCSA compliance.
Scale indicators14 records
Recent moves7 records
Expansion highlights5 records
AmerisourceBergen competitors and assessment
Company assessmentDirect peers
- McKesson Corporation: Largest U.S. pharmaceutical distributor and direct competitor; operates the same wholesale and specialty distribution model across manufacturers, pharmacies, and health systems, with overlapping Big-3 scale positioning.
- Cardinal Health: One of the Big 3 U.S. pharmaceutical wholesalers; competes head-to-head with Cencora on the same manufacturer-to-pharmacy distribution model and adds medical product distribution through its medical segment.
- Patterson Companies: Veterinary and dental product distributor; directly comparable to Cencora's MWI Veterinary Supply franchise on customer base (veterinarians and dental practices), product breadth, and B2B distribution model.
- Covetrus: Pure-play animal health distributor (spun out of Henry Schein's animal health business); directly comparable to Cencora's MWI veterinary supply operations as the other scaled vet-focused wholesaler in the U.S. market.
- Henry Schein: Healthcare distribution leader across dental, medical, and remaining animal health; an adjacent B2B healthcare distribution franchise with comparable scaled practice-customer reach and federal/public-sector exposure.
- Owens & Minor: Medical/surgical product distributor serving hospitals and providers; a comparable supply-chain logistics footprint and fixed-cost distribution model with overlap in patient-direct and home health distribution channels.
Broad incumbents
- IQVIA: Global life sciences services firm offering commercialization, market access, and real-world data services that overlap with Cencora's manufacturer solutions and patient access services for emerging and large pharma alike.
- ICON plc: Clinical research and contract services organization with adjacent post-launch commercialization and patient access offerings that overlap with Cencora's manufacturer services arm.
- Zoetis: Leading global animal health manufacturer that uses Cencora's MWI distribution services; an upstream counterpart in the animal-health value chain capturing the manufacturer side of the same end market.
Others
- DHL Supply Chain (Life Sciences & Healthcare): Global contract logistics provider competing for pharmaceutical 3PL, cold chain, and specialty distribution business adjacent to Cencora's outsourced logistics and specialty distribution franchises.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks6 records
Key highlights7 records
Customer concentration
AmerisourceBergen social profiles
Digital presenceAmerisourceBergen financial estimates
Financial estimateRevenue estimate
Valuation estimate
AmerisourceBergen leadership team
Management profileNumber of profiles
Profiles11 records
AmerisourceBergen subsidiaries and ownership
Company hierarchySubsidiaries15 records
AmerisourceBergen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AmerisourceBergen M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AmerisourceBergen
What does AmerisourceBergen do?
AmerisourceBergen (now Cencora) is a global pharmaceutical distribution company that provides wholesale and specialty distribution services moving medications from 1,300+ manufacturers to 180K+ dispensing points through 56 distribution centers. The company also offers manufacturer solutions (market access, regulatory consulting, patient access services), provider solutions for pharmacies, physician practices, hospitals and health systems, and animal health distribution for veterinarians and livestock producers.
Is AmerisourceBergen a public or private company?
AmerisourceBergen is a public company. It is classified as public and is currently operating.
When was AmerisourceBergen founded?
AmerisourceBergen was founded in 1871. It employs 5,001 to 10,000 people.
Where is AmerisourceBergen based?
AmerisourceBergen is headquartered in Seminole, United States, in the North America region.
How does AmerisourceBergen make money?
Six revenue lines are on record. Wholesale Pharmaceutical Distribution is the primary driver. The others are specialty Distribution, manufacturer Solutions, pharmacy and Provider Solutions, animal Health Distribution and marketplace Commerce.
Who are AmerisourceBergen's main competitors?
Direct peers on record are McKesson Corporation, Cardinal Health, Patterson Companies, Covetrus, Henry Schein and Owens & Minor. Broad incumbents are IQVIA, ICON plc and Zoetis. DHL Supply Chain (Life Sciences & Healthcare) is listed as an others.
Does AmerisourceBergen have an API?
No public API is recorded for AmerisourceBergen.